Pharma & Bio
Technology
D&D Pharmatech Rises on Hopes of a Major Deal; Aimed Bio and ImmuneOncia Slide [K-Bio Pulse]
D&D Pharmatech Inc. stood out in a weak biotech market on June 4, surging on expectations for a potential licensing deal related to metabolic dysfunction-associated steatohepatitis (MASH). In contrast…
Technology
D&D Pharmatech Rises on Big Deal Expectations… Aimed Bio and Immune Oncia Down [Bio Market Watch]
On the 4th, in the biotech and healthcare sector, #DNDPharmatech surged on expectations of a technology transfer related to metabolic dysfunction-associated steatohepatitis (MASH), making its presence…
Technology
Pharos iBio Joins Eli Lilly’s ‘TuneLab’… to Utilize NVIDIA AI Platform [Exclusive to Edaily]
#Pharos iBio, a South Korean company specializing in AI-driven drug discovery, has joined forces with global pharmaceutical giant Eli Lilly. Pharos iBio has officially signed a strategic cooperation a…
Lifestyle
“Enaprazu Selling Out Due to High Demand”… Bivon Pharmaceutical to Produce 120,000 Additional Vials [Bio Spotlight]
On the 2nd, companies in the domestic pharmaceutical and biotech industry drew market attention for their successive achievements, including clinical progress, expanded production, and major technolog…
Business·Industry
Hong Jong-ho, CEO of KUKJEON: “We’re Making a Bold Move to Expand Our Business into Advanced Materials, from Active Pharmaceutical Ingredients to AI Semiconductor Packaging”
“KUKJEON PHARMACEUTICAL Co.,Ltd(307750)is a company that is extending new branches into fine chemicals and materials while remaining rooted in its core business of pharmaceuticals.”
Hong Jong-ho, C…
Lifestyle
Only the Core Technology Survives as AI-Labeled Biotech Companies Fade Away
Global capital markets are growing increasingly wary of so-called “AI washing.” As companies that have lured investors by touting AI technology find themselves in the crosshairs of judicial authoritie…
Lifestyle
Ciers Completes Rollout of 'Think' at Samsung Seoul Hospital... Solidifying Its Position as the Market Leader in Patient Monitoring [Exclusive to Edaily]
#Ciers has signed a contract with Samsung Seoul Hospital, one of Korea’s leading medical institutions, to supply its inpatient monitoring platform, “thynC.” As the AI-based patient monitoring market b…